Modulation of PPAR activity via phosphorylation

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 8, 2007, Pages 952-960

  Burns, Katherine A ^a   Vanden Heuvel, John P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Gene expression; Glycogen synthase kinase 3; Mitogen activated protein kinase; Nuclear receptor; Peroxisome proliferator activated receptor; Protein kinase A; Protein kinase C; Protein phosphorylation; Transcriptional regulation

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE;

HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GROWTH SUBSTANCES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHORYLATION; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; PPAR-BETA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 34547589477     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.04.018     Document Type: Review

References (68)

1. N.R.N. Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 97 (1999) 161-163
2. Escher P., and Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 448 (2000) 121-138
3. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
4. Fajas L., Auboeuf D., Raspe E., Schoonjans K., Lefebvre A.M., Saladin R., Najib J., Laville M., Fruchart J.C., Deeb S., Vidal-Puig A., Flier J., Briggs M.R., Staels B., Vidal H., and Auwerx J. The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272 (1997) 18779-18789
5. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
6. Gottlicher M., Widmark E., Li Q., and Gustafsson J.A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4653-4657
7. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., and Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 (1992) 879-887
8. Sher T., Yi H.F., McBride O.W., and Gonzalez F.J. cDna cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32 (1993) 5598-5604
9. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., Saperstein R., Smith R.G., and Leibowitz M.D. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 (1996) 4189-4195
10. Dowell P., Peterson V.J., Zabriskie T.M., and Leid M. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J. Biol. Chem. 272 (1997) 2013-2020
11. E.S. Tien, D.B. Hannon, J.T. Thompson, J.P. Vanden Heuvel, Examination of ligand-dependent coactivator recruitment by Peroxisome Proliferator-Activated Receptor-α, PPAR Research 1 (2006) 1-9.
12. Sumanasekera W.K., Tien E.S., Turpey R., Vanden Heuvel J.P., and Perdew G.H. Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J. Biol. Chem. 278 (2003) 4467-4473
13. Sumanasekera W.K., Tien E.S., Davis II J.W., Turpey R., Perdew G.H., and Vanden Heuvel J.P. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Biochemistry 42 (2003) 10726-10735
14. Patel H., Truant R., Rachubinski R.A., and Capone J.P. Activity and subcellular compartmentalization of peroxisome proliferator-activated receptor alpha are altered by the centrosome-associated protein CAP350. J. Cell. Sci. 118 (2005) 175-186
15. Akiyama T.E., Baumann C.T., Sakai S., Hager G.L., and Gonzalez F.J. Selective intranuclear redistribution of PPAR isoforms by RXR alpha. Mol. Endocrinol. 16 (2002) 707-721
16. El-Tanani M.K., and Green C.D. Two separate mechanisms for ligand-independent activation of the estrogen receptor. Mol. Endocrinol. 11 (1997) 928-937
17. Smith C.L. Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol. Reprod. 58 (1998) 627-632
18. Bunone G., Briand P.A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15 (1996) 2174-2183
19. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzer D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen- activated protein kinase. Science 270 (1995) 1491-1494
20. Vanden Heuvel J.P. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. Toxicol. Sci. 47 (1999) 1-8
21. Rokos C.L., and Ledwith B.J. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J. Biol. Chem. 272 (1997) 13452-13457
22. Ledwith B.J., Johnson T.E., Wagner L.K., Pauley C.J., Manam S., Galloway S.M., and Nichols W.W. Growth regulation by peroxisome proliferators: opposing activities in early and late G1. Cancer Res. 56 (1996) 3257-3264
23. Lazennec G., Canaple L., Saugy D., and Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14 (2000) 1962-1975
24. Zhou Y.C., and Waxman D.J. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor- alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b. J. Biol. Chem. 274 (1999) 2672-2681
25. Vanden Heuvel J.P. Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis. J. Nutr. 129 (1999) 575S-580S
26. Shalev A., Siegrist-Kaiser C.A., Yen P.M., Wahli W., Burger A.G., Chin W.W., and Meier C.A. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137 (1996) 4499-4502
27. Passilly P., Schohn H., Jannin B., Malki M.C., Boscoboinik D., Dauca M., and Latruffe N. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate. Biochem. Pharmacol. 58 (1999) 1001-1008
28. Juge-Aubry C.E., Hammar E., Siegrist-Kaiser C., Pernin A., Takeshita A., Chin W.W., Burger A.G., and Meier C.A. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274 (1999) 10505-10510
29. Vanden Heuvel J.P., Kreder D., Belda B., Hannon D.B., Nugent C.A., Burns K.A., and Taylor M.J. Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643. Toxicol. Appl. Pharmacol. 188 (2003) 185-198
30. Barger P.M., Browning A.C., Garner A.N., and Kelly D.P. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J. Biol. Chem. 276 (2001) 44495-44501
31. Barger P.M., Brandt J.M., Leone T.C., Weinheimer C.J., and Kelly D.P. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J. Clin. Invest. 105 (2000) 1723-1730
32. Martin G., Duez H., Blanquart C., Berezowski V., Poulain P., Fruchart J.C., Najib-Fruchart J., Glineur C., and Staels B. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. J. Clin. Invest. 107 (2001) 1423-1432
33. Gray J.P., Burns K.A., Leas T.L., Perdew G.H., and Vanden Heuvel J.P. Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C. Biochemistry 44 (2005) 10313-10321
34. Blanquart C., Mansouri R., Paumelle R., Fruchart J.C., Staels B., and Glineur C. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha. Mol. Endocrinol. 18 (2004) 1906-1918
35. Lee W.J., Kim M., Park H.S., Kim H.S., Jeon M.J., Oh K.S., Koh E.H., Won J.C., Kim M.S., Oh G.T., Yoon M., Lee K.U., and Park J.Y. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem. Biophys. Res. Commun. 340 (2006) 291-295
36. Yoon M.J., Lee G.Y., Chung J.J., Ahn Y.H., Hong S.H., and Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55 (2006) 2562-2570
37. ter Haar E., Coll J.T., Austen D.A., Hsiao H.M., Swenson L., and Jain J. Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8 (2001) 593-596
38. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 (2001) 1-16
39. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
40. Lazennec G., Canaple L., Saugy D., and Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol. Endocrinol. 14 (2000) 1962-1975
41. Hansen J.B., Zhang H., Rasmussen T.H., Petersen R.K., Flindt E.N., and Kristiansen K. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J. Biol. Chem. 276 (2001) 3175-3182
42. Krogsdam A.M., Nielsen C.A., Neve S., Holst D., Helledie T., Thomsen B., Bendixen C., Mandrup S., and Kristiansen K. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. Biochem. J. 363 (2002) 157-165
43. Han S., Ritzenthaler J.D., Wingerd B., and Roman J. Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta. J. Biol. Chem. 280 (2005) 33240-33249
44. Kramer D.K., Al-Khalili L., Perrini S., Skogsberg J., Wretenberg P., Kannisto K., Wallberg-Henriksson H., Ehrenborg E., Zierath J.R., and Krook A. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. Diabetes 54 (2005) 1157-1163
45. Hu E., Kim J.B., Sarraf P., and Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274 (1996) 2100-2103
46. Adams M., Reginato M.J., Shao D., Lazar M.A., and Chatterjee V.K. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen- activated protein kinase site. J. Biol. Chem. 272 (1997) 5128-5132
47. Camp H.S., and Tafuri S.R. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272 (1997) 10811-10816
48. Zhang B., Berger J., Zhou G., Elbrecht A., Biswas S., White-Carrington S., Szalkowski D., and Moller D.E. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 271 (1996) 31771-31774
49. Camp H.S., Tafuri S.R., and Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 140 (1999) 392-397
50. Shao D.L., Rangwala S.M., Bailey S.T., Krakow S.L., Reginato M.J., and Lazar M.A. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 396 (1998) 377-380
51. Han J., Hajjar D.P., Tauras J.M., Feng J., Gotto Jr. A.M., and Nicholson A.C. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 275 (2000) 1241-1246
52. Rochette-Egly C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell Signal 15 (2003) 355-366
53. Floyd Z.E., and Stephens J.M. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 277 (2002) 4062-4068
54. Ristow M., Muller-Wieland D., Pfeiffer A., Krone W., and Kahn C.R. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339 (1998) 953-959
55. Rangwala S.M., Rhoades B., Shapiro J.S., Rich A.S., Kim J.K., Shulman G.I., Kaestner K.H., and Lazar M.A. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev. Cell 5 (2003) 657-663
56. Akahoshi T., Namai R., Murakami Y., Watanabe M., Matsui T., Nishimura A., Kitasato H., Kameya T., and Kondo H. Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum. 48 (2003) 231-239
57. Sotiropoulos K.B., Clermont A., Yasuda Y., Rask-Madsen C., Mastumoto M., Takahashi J., Della Vecchia K., Kondo T., Aiello L.P., and King G.L. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J. 20 (2006) 1203-1205
58. Leff T. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem. Soc. Trans. 31 (2003) 224-227
59. LeBrasseur N.K., Kelly M., Tsao T.S., Farmer S.R., Saha A.K., Ruderman N.B., and Tomas E. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am. J. Physiol., Endocrinol. Metabol. 291 (2006) E175-E181
60. Gampe R.T.J., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., Milburn M.V., Kliewer S.A., Willson T.M., and Xu H.E. Asymmetry in the PPARg/RXRa crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Molec. Cell 5 (2000) 545-555
61. Gorla-Bajszczak A., Juge-Aubry C., Pernin A., Burger A.G., and Meier C.A. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR. Mol. Cell Endocrinol. 147 (1999) 37-47
62. Roberts R.A., James N.H., Woodyatt N.J., Macdonald N., and Tugwood J.D. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis 19 (1998) 43-48
63. Gervois P., Torra I.P., Chinetti G., Grotzinger T., Dubois G., Fruchart J.C., Fruchart-Najib J., Leitersdorf E., and Staels B. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol. Endocrinol. 13 (1999) 1535-1549
64. Gurnell M., Wentworth J.M., Agostini M., Adams M., Collingwood T.N., Provenzano C., Browne P.O., Rajanayagam O., Burris T.P., Schwabe J.W., Lazar M.A., and Chatterjee V.K. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J. Biol. Chem. 275 (2000) 5754-5759
65. Chen S., Johnson B.A., Li Y., Aster S., McKeever B., Mosley R., Moller D.E., and Zhou G. Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor gamma (PPARgamma) function. J. Biol. Chem. 275 (2000) 3733-3736
66. Juge-Aubry C., Pernin A., Favez T., Burger A.G., Wahli W., Meier C.A., and Desvergne B. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region. J. Biol. Chem. 272 (1997) 25252-25259
67. Shao D., Rangwala S.M., Bailey S.T., Krakow S.L., Reginato M.J., and Lazar M.A. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 396 (1998) 377-380
68. Deeb S.S., Fajas L., Nemoto M., Pihlajamaeki J., Mykkaenen L., Kuusisto J., Laakso M., Fujimoto W., and Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20 (1998) 284-287